Fig. 4From: Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinomaThe Kaplan–Meier survival analysis of the signature for both training set and testing sets. Patients with high risk score demonstrated poor OS than those with low risk score in TCGA dataset (a), GSE30219 (b), GSE31210 (c), GSE81089 (d), and GSE3141 (e), which suggested the robust predictive ability for LUAD patients’ survival outcome (P < 0.001). TCGA The Cancer Genome AtlasBack to article page